Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort

Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort

<strong>Background:</strong> Most studies on hepatitis C virus (HCV)/HIV-coinfection do not account for the order and duration of these two infections. We aimed to assess the effect of incident HCV infection, and its timing relative to HIV seroconversion (HIVsc) in HIV-positive MSM on th...

Full description

Bibliographic Details
Main Authors:	Van Santen, D, Van Der Helm, J, Touloumi, G, Pantazis, N, Muga, R, Gunsenheimer-Bartmeyer, B, Gill, M, Sanders, E, Kelleher, A, Zangerle, R, Porter, K, Prins, M, Geskus, R, Cascade Collaboration Within Eurocoord
Format:	Journal article
Language:	English
Published:	Wolters Kluwer Health 2019

Similar Items

Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection.
by: Sara Lodi, et al.
Published: (2013-01-01)

Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.
by: CASCADE Collaboration
Published: (2003)

Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.
by: Smit, C, et al.
Published: (2006)

Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates.
by: Touloumi, G, et al.
Published: (2004)

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.
by: Giota Touloumi, et al.
Published: (2013-01-01)

HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors
by: Dimitrios Paraskevis, et al.
Published: (2019-01-01)

Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?
by: Concerted Action on SeroConversion to AIDS and Death in Europe (CASCADE Collaboration)
Published: (2001)

Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990–2014
by: van Santen, D, et al.
Published: (2017)

Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990–2014
by: van Santen, D, et al.
Published: (2017)

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion
by: Stirrup, O, et al.
Published: (2017)

Determinants of response to first HAART regimen in antiretroviral-naive patients with an estimated time since HIV seroconversion.
by: Thiébaut, R, et al.
Published: (2006)

Imputation of the Date of HIV Seroconversion in a Cohort of Seroprevalent Subjects: Implications for Analysis of Late HIV Diagnosis
by: Paz Sobrino-Vegas, et al.
Published: (2012-01-01)

Impact of tuberculosis on HIV disease progression in persons with well-documented time of HIV seroconversion.
by: Del Amo, J, et al.
Published: (2003)

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.
by: Porter, K, et al.
Published: (2003)

Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors.
by: Bhaskaran, K, et al.
Published: (2004)

How soon after HIV seroconversion is antiretroviral therapy initiated?
by: Babiker, A, et al.
Published: (1999)

The relationship between HIV seroconversion illness, HIV test interval and time to AIDS in a seroconverter cohort.
by: Tyrer, F, et al.
Published: (2003)

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.
by: Nikos Pantazis, et al.
Published: (2012-01-01)

HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014.
by: Ruth Simmons, et al.
Published: (2015-01-01)

High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany.
by: Klaus Jansen, et al.
Published: (2015-01-01)

An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration.
by: Ashley D Olson, et al.
Published: (2014-01-01)

HIV-prevalence in tuberculosis patients in Germany, 2002-2009: an estimation based on HIV and tuberculosis surveillance data.
by: Lena Fiebig, et al.
Published: (2012-01-01)

HIV-seroconversion among HIV-1 serodiscordant married couples in Tanzania: a cohort study
by: Soledad Colombe, et al.
Published: (2019-06-01)

Penile bacteria associated with HIV seroconversion, inflammation, and immune cells
by: Jessica L. Prodger, et al.
Published: (2021-04-01)

Developing a next level integrated genomic surveillance: Advances in the molecular epidemiology of HIV in Germany
by: Kirsten Hanke, et al.
Published: (2024-03-01)

HIV prevention and missed opportunities among people with recently acquired HIV infection: Α protocol for a systematic review.
by: Argyro Karakosta, et al.
Published: (2024-01-01)

Bilateral lower motor neuron facial nerve palsy due to HIV seroconversion
by: R Dolan, et al.
Published: (2011-04-01)

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks.
by: Babiker, A, et al.
Published: (2002)

Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe.
by: Babiker, A, et al.
Published: (2000)

Sustained Mpox Proctitis with Primary Syphilis and HIV Seroconversion, Australia
by: Rachel M. Burdon, et al.
Published: (2023-03-01)

Measles mimicking HIV seroconversion syndrome: a case report
by: Brook Gary, et al.
Published: (2010-02-01)

Prevalence, incidence and seroconversion of HIV and Syphilis infections among pregnant women of South Africa
by: Monjurul Hoque, et al.
Published: (2021-11-01)

High HIV-1 incidence, correlates of HIV-1 acquisition, and high viral loads following seroconversion among men who have sex with men in Coastal Kenya.
by: Sanders, E, et al.
Published: (2013)

Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.
by: Kaul, R, et al.
Published: (2001)

Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice.
by: Touloumi, G, et al.
Published: (2008)

HIV Incidence Estimates Using the Limiting Antigen Avidity EIA Assay at Testing Sites in Kiev City, Ukraine: 2013-2014.
by: Ruth Simmons, et al.
Published: (2016-01-01)

High level of plasma TILRR protein is associated with faster HIV seroconversion
by: Mohammad Abul Kashem, et al.
Published: (2022-04-01)

Misuse of PrEP and atypical HIV seroconversion: about a case
by: Hélène Laroche, et al.
Published: (2018-05-01)

Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort.
by: Fidler, S, et al.
Published: (2007)

Aging with HIV vs. HIV seroconversion at older age: a diverse population with distinct comorbidity profiles.
by: Giovanni Guaraldi, et al.
Published: (2015-01-01)